Today, Remedy released its latest quarterly report for the period between October and December 2023. Despite the successful launch of Alan Wake 2, which was the fastest-selling game ever made by the studio even launching in a highly competitive release window, Q4 2023 marked a decrease in both revenue and profitability compared to 2022 due to significantly increased investments in the other game projects and to the impairment charge cost (€ -7.2 million) related to the reboot of the free-to-play Project Vanguard, from now on known as Kestrel.